Phytochemical modulators of mitochondria: The search for chemopreventive agents and supportive therapeutics

Pharmaceuticals

Volumn 7, Issue 9, 2014, Pages 913-942

  Grabacka, Maja M ^a   Gawin, Malgorzata ^a   Pierzchalska, Malgorzata ^a  

^a UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

Cancer; Curcumin; Longevity; Respiration; Resveratrol; Retrograde and anterograde signaling; Sulforaphane

Indexed keywords

ADENOSINE TRIPHOSPHATE; CURCUMIN; EPIGALLOCATECHIN GALLATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1; SULFORAPHANE; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BIOGENESIS; CANCER PREVENTION; CANCER STEM CELL; CELL CYCLE ARREST; CELL PROTECTION; CHEMICAL MODIFICATION; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG STRUCTURE; HUMAN; LIFESPAN; MAXIMUM PLASMA CONCENTRATION; METABOLIC SYNDROME X; MITOCHONDRIAL GENOME; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84923644280     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph7090913     Document Type: Review

References (163)

1. Van der Giezen, M. Hydrogenosomes and mitosomes: Conservation and evolution of functions. J. Eukaryotic. Microbiol. 2009, 56, 221-231
2. Shiflett, A.M.; Johnson, P.J. Mitochondrion-related organelles in eukaryotic protists. Annu. Rev. Microbiol. 2010, 64, 409-429
3. Lill, R.; Muhlenhoff, U. Iron-sulfur-protein biogenesis in eukaryotes. Trends Biochem. Sci. 2005, 30, 133-141
4. Van der Giezen, M.; Tovar, J. Mitosomes, Hydrogenosomes and Mitochondria: Variations on a Theme? In Organelles, Genomes and Eiukaryote Phylogeny; an Evolutionary Synthesis in the Age of Genomics; Hirt, R.P., Horner, D.S., Eds.; CRC Press: Boca Raton, FL, USA, 2004; pp. 329-351
5. Miller, S.W.; Trimmer, P.A.; Parker, W.D., Jr.; Davis, R.E. Creation and characterization of mitochondrial DNA-depleted cell lines with “neuronal-like” properties. J. Neurochem. 1996, 67, 1897-1907
6. Chandel, N.S.; Schumacker, P.T. Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS Lett. 1999, 454, 173-176
7. Baron, M.; Kudin, A.P.; Kunz, W.S. Mitochondrial dysfunction in neurodegenerative disorders. Biochem. Soc. Trans. 2007, 35, 1228-1231
8. Patti, M.E.; Corvera, S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocrine Rev. 2010, 31, 364-395
9. Taylor, R.W.; Turnbull, D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6, 389-402
10. Wallace, D.C. Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 1992, 256, 628-632
11. Trifunovic, A.; Wredenberg, A.; Falkenberg, M.; Spelbrink, J.N.; Rovio, A.T.; Bruder, C.E.; Bohlooly, Y.M.; Gidlof, S.; Oldfors, A.; Wibom, R. et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429, 417-423
12. Alvarez, V.; Corao, A.I.; Alonso-Montes, C.; Sanchez-Ferrero, E.; De Mena, L.; Morales, B.; Garcia-Castro, M.; Coto, E. Mitochondrial transcription factor a (tfam) gene variation and risk of late-onset alzheimer's disease. J. Alzheimer’s Dis. 2008, 13, 275-280
13. Belin, A.C.; Bjork, B.F.; Westerlund, M.; Galter, D.; Sydow, O.; Lind, C.; Pernold, K.; Rosvall, L.; Hakansson, A.; Winblad, B. et al. Association study of two genetic variants in mitochondrial transcription factor a (tfam) in alzheimer's and parkinson's disease. Neurosci. Lett. 2007, 420, 257-262
14. Gunther, C.; von Hadeln, K.; Muller-Thomsen, T.; Alberici, A.; Binetti, G.; Hock, C.; Nitsch, R.M.; Stoppe, G.; Reiss, J.; Gal, A. et al. Possible association of mitochondrial transcription factor a (tfam) genotype with sporadic alzheimer disease. Neurosci. Lett. 2004, 369, 219-223
15. Gaweda-Walerych, K.; Safranow, K.; Maruszak, A.; Bialecka, M.; Klodowska-Duda, G.; Czyzewski, K.; Slawek, J.; Rudzinska, M.; Styczynska, M.; Opala, G. et al. Mitochondrial transcription factor a variants and the risk of parkinson’s disease. Neurosci. Lett. 2010, 469, 24-29
16. Alvarez, V.; Corao, A.I.; Sanchez-Ferrero, E.; De Mena, L.; Alonso-Montes, C.; Huerta, C.; Blazquez, M.; Ribacoba, R.; Guisasola, L.M.; Salvador, C et al. Mitochondrial transcription factor a (tfam) gene variation in parkinson’s disease. Neurosci. Lett. 2008, 432, 79-82
17. Gonzalez, J.R.; Caceres, A.; Esko, T.; Cusco, I.; Puig, M.; Esnaola, M.; Reina, J.; Siroux, V.; Bouzigon, E.; Nadif, R. et al. A common 16p11.2 inversion underlies the joint susceptibility to asthma and obesity. Am. J. Hum. Genetics 2014, 94, 361-372
18. He, Y.; Wu, J.; Dressman, D.C.; Iacobuzio-Donahue, C.; Markowitz, S.D.; Velculescu, V.E.; Diaz, L.A., Jr.; Kinzler, K.W.; Vogelstein, B.; Papadopoulos, N. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 2010, 464, 610-614
19. Coller, H.A.; Khrapko, K.; Bodyak, N.D.; Nekhaeva, E.; Herrero-Jimenez, P.; Thilly, W.G. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 2001, 28, 147-150
20. Kazi, A.; Smith, D.M.; Zhong, Q.; Dou, Q.P. Inhibition of bcl-x-l phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis. Mol. Pharmacol. 2002, 62, 765-771
21. Zhao, Y.; Yang, L.F.; Ye, M.; Gu, H.H.; Cao, Y. Induction of apoptosis by epigallocatechin-3-gallate via mitochondrial signal transduction pathway. Prev. Med. 2004, 39, 1172-1179
22. Nihal, M.; Ahmad, N.; Mukhtar, H.; Wood, G.S. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: Possible implications for the chemoprevention of melanoma. Int. J. Cancer 2005, 114, 513-521
23. Roy, A.M.; Baliga, M.S.; Katiyar, S.K. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and bax and caspase-3 activation. Mol. Cancer Ther. 2005, 4, 81-90
24. Qanungo, S.; Das, M.; Haldar, S.; Basu, A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 2005, 26, 958-967
25. Shankar, S.; Suthakar, G.; Srivastava, R.K. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front. Biosci. 2007, 12, 5039-5051
26. Ran, Z.H.; Xu, Q.; Tong, J.L.; Xiao, S.D. Apoptotic effect of epigal locatechin-3-gallate on the human gastric cancer cell line mkn45 via activation of the mitochondrial pathway. World J. Gastroentero 2007, 13, 4255-4259
27. Singh, M.; Bhui, K.; Singh, R.; Shukla, Y. Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis. Life Sci. 2013, 93, 7-16
28. Singh, M.; Singh, R.; Bhui, K.; Tyagi, S.; Mahmood, Z.; Shukla, Y. Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappab and akt activation in human cervical cancer cells. Oncol. Res. 2011, 19, 245-257
29. Li, W.; Nie, S.; Yu, Q.; Xie, M. (-)-epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species. J. Agric. Food Chem. 2009, 57, 6685-6691
30. Kil, I.S.; Jung, K.H.; Nam, W.S.; Park, J.W. Attenuated mitochondrial NADP+ dependent isocitrate dehydrogenase activity enhances egcg-induced apoptosis. Biochimie 2011, 93, 1808-1815
31. Valenti, D.; de Bari, L.; Manente, G.A.; Rossi, L.; Mutti, L.; Moro, L.; Vacca, R.A. Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells. Biochim. Biophys. Acta 2013, 1832, 2085-2096
32. Meng, Q.; Velalar, C.N.; Ruan, R. Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Radic. Biol. Med. 2008, 44, 1032-1041
33. Carrasco-Pozo, C.; Mizgier, M.L.; Speisky, H.; Gotteland, M. Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in caco-2 cells. Chemico-Biol. Interact. 2012, 195, 199-205
34. Fiorani, M.; Guidarelli, A.; Blasa, M.; Azzolini, C.; Candiracci, M.; Piatti, E.; Cantoni, O. Mitochondria accumulate large amounts of quercetin: Prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J. Nutr. Biochem. 2010, 21, 397-404
35. Pham, J.; Brownlow, B.; Elbayoumi, T. Mitochondria-specific pro-apoptotic activity of genistein lipidic nanocarriers. Mol. Pharm. 2013, 10, 3789-3800
36. Cavallito, C.J.; Bailey, J.H. Allicin—isolation and antibacterial properties. Am. J. Chem. Soc. 1944, 66, 1950-1951
37. Davis, S.R. An overview of the antifungal properties of allicin and its breakdown products—the possibility of a safe and effective antifungal prophylactic. Mycoses 2005, 48, 95-100
38. Park, S.Y.; Cho, S.J.; Kwon, H.C.; Lee, K.R.; Rhee, D.K.; Pyo, S. Caspase-independent cell death by allicin in human epithelial carcinoma cells: Involvement of pka. Cancer Lett. 2005, 224, 123-132
39. Oommen, S.; Anto, R.J.; Srinivas, G.; Karunagaran, D. Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. Eur. J. Pharmacol. 2004, 485, 97-103
40. Miron, T.; Wilchek, M.; Sharp, A.; Nakagawa, Y.; Naoi, M.; Nozawa, Y.; Akao, Y. Allicin inhibits cell growth and induces apoptosis through the mitochondrial pathway in hl60 and u937 cells. J. Nutr. Biochem. 2008, 19, 524-535
41. Miron, T.; Rabinkov, A.; Mirelman, D.; Wilchek, M.; Weiner, L. The mode of action of allicin: Its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim. Biophys. Acta 2000, 1463, 20-30
42. Rabinkov, A.; Miron, T.; Mirelman, D.; Wilchek, M.; Glozman, S.; Yavin, E.; Weiner, L. S-allylmercaptoglutathione: The reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim. Biophys. Acta 2000, 1499, 144-153
43. Sareen, D.; Darjatmoko, S.R.; Albert, D.M.; Polans, A.S. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol. Pharmacol. 2007, 72, 1466-1475
44. Higashida, K.; Kim, S.H.; Jung, S.R.; Asaka, M.; Holloszy, J.O.; Han, D.H. Effects of resveratrol and sirt1 on pgc-1alpha activity and mitochondrial biogenesis: A reevaluation. PLoS Biol. 2013, 11, e1001603
45. Beher, D.; Wu, J.; Cumine, S.; Kim, K.W.; Lu, S.C.; Atangan, L.; Wang, M. Resveratrol is not a direct activator of sirt1 enzyme activity. Chem. Biol. Drug Des. 2009, 74, 619-624
46. Pacholec, M.; Bleasdale, J.E.; Chrunyk, B.; Cunningham, D.; Flynn, D.; Garofalo, R.S.; Griffith, D.; Griffor, M.; Loulakis, P.; Pabst, B. et al. Srt1720, srt2183, srt1460, and resveratrol are not direct activators of sirt1. J. Biol. Chem. 2010, 285, 8340-8351
47. Jager, S.; Handschin, C.; St-Pierre, J.; Spiegelman, B.M. Amp-activated protein kinase (ampk) action in skeletal muscle via direct phosphorylation of pgc-1alpha. Proc. Nat. Acad. Sci. USA 2007, 104, 12017-12022
48. Rodgers, J.T.; Lerin, C.; Haas, W.; Gygi, S.P.; Spiegelman, B.M.; Puigserver, P. Nutrient control of glucose homeostasis through a complex of pgc-1alpha and sirt1. Nature 2005, 434, 113-118
49. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating sirt1 and pgc-1alpha. Cell 2006, 127, 1109-1122
50. Murase, T.; Haramizu, S.; Ota, N.; Hase, T. Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice. Biogerontology 2009, 10, 423-434
51. Hart, N.; Sarga, L.; Csende, Z.; Koltai, E.; Koch, L.G.; Britton, S.L.; Davies, K.J.; Kouretas, D.; Wessner, B.; Radak, Z. Resveratrol enhances exercise training responses in rats selectively bred for high running performance. Food Chem. Toxicol. 2013, 61, 53-59
52. Um, J.H.; Park, S.J.; Kang, H.; Yang, S.; Foretz, M.; McBurney, M.W.; Kim, M.K.; Viollet, B.; Chung, J.H. Amp-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59, 554-563
53. Menzies, K.J.; Singh, K.; Saleem, A.; Hood, D.A. Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J. Biol. Chem. 2013, 288, 6968-6979
54. Hart, N.; Sarga, L.; Csende, Z.; Koch, L.G.; Britton, S.L.; Davies, K.J.; Radak, Z. Resveratrol attenuates exercise-induced adaptive responses in rats selectively bred for low running performance. Dose-Response 2014, 12, 57-71
55. Lim, H.W.; Lim, H.Y.; Wong, K.P. Uncoupling of oxidative phosphorylation by curcumin: Implication of its cellular mechanism of action. Biochem. Biophys. Res. Commun. 2009, 389, 187-192
56. Negrette-Guzman, M.; Huerta-Yepez, S.; Tapia, E.; Pedraza-Chaverri, J. Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: A seemingly contradictory dual role and an integrative hypothesis. Free Rad. Biol. Med. 2013, 65, 1078-1089
57. Pham, T.X.; Lee, J. Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases. Nutrients 2012, 4, 1868-1886
58. Mitsuishi, Y.; Taguchi, K.; Kawatani, Y.; Shibata, T.; Nukiwa, T.; Aburatani, H.; Yamamoto, M.; Motohashi, H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012, 22, 66-79
59. Holmstrom, K.M.; Baird, L.; Zhang, Y.; Hargreaves, I.; Chalasani, A.; Land, J.M.; Stanyer, L.; Yamamoto, M.; Dinkova-Kostova, A.T.; Abramov, A.Y. Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol. Open 2013, 2, 761-770
60. Brose, R.D.; Shin, G.; McGuinness, M.C.; Schneidereith, T.; Purvis, S.; Dong, G.X.; Keefer, J.; Spencer, F.; Smith, K.D. Activation of the stress proteome as a mechanism for small molecule therapeutics. Human Mol. Genet. 2012, 21, 4237-4252
61. Li, Y.G.; Zhu, W.; Tao, J.P.; Xin, P.; Liu, M.Y.; Li, J.B.; Wei, M. Resveratrol protects cardiomyocytes from oxidative stress through sirt1 and mitochondrial biogenesis signaling pathways. Biochem. Biophys. Res. Commun. 2013, 438, 270-276
62. Leonard, S.S.; Xia, C.; Jiang, B.H.; Stinefelt, B.; Klandorf, H.; Harris, G.K.; Shi, X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003, 309, 1017-1026
63. Vina, J.; Gomez-Cabrera, M.C.; Borras, C.; Froio, T.; Sanchis-Gomar, F.; Martinez-Bello, V.E.; Pallardo, F.V. Mitochondrial biogenesis in exercise and in ageing. Adv. Drug Deliv. Rev. 2009, 61, 1369-1374
64. Cheng, P.W.; Ho, W.Y.; Su, Y.T.; Lu, P.J.; Chen, B.Z.; Cheng, W.H.; Lu, W.H.; Sun, G.C.; Yeh, T.C.; Hsiao, M. et al. Resveratrol decreases fructose-induced oxidative stress, mediated by nadph oxidase via an ampk-dependent mechanism. Br. J. Pharmacol. 2014, 171, 2739-2750
65. Quincozes-Santos, A.; Bobermin, L.D.; Tramontina, A.C.; Wartchow, K.M.; Tagliari, B.; Souza, D.O.; Wyse, A.T.; Goncalves, C.A. Oxidative stress mediated by nmda, ampa/ka channels in acute hippocampal slices: Neuroprotective effect of resveratrol. Toxicol. In Vitro 2014, 28, 544-551
66. Qin, S.; Lu, Y.; Rodrigues, G.A. Resveratrol protects rpe cells from sodium iodate by modulating pparalpha and ppardelta. Exp. Eye Res. 2014, 118, 100-108
67. Mokni, M.; Hamlaoui, S.; Karkouch, I.; Amri, M.; Marzouki, L.; Limam, F.; Aouani, E. Resveratrol provides cardioprotection after ischemia/reperfusion injury via modulation of antioxidant enzyme activities. Iran. J. Pharm. Res. 2013, 12, 867-875
68. Shakibaei, M.; Harikumar, K.B.; Aggarwal, B.B. Resveratrol addiction: To die or not to die. Mol. Nutr. Food Res. 2009, 53, 115-128
69. Morin, C.; Zini, R.; Albengres, E.; Bertelli, A.A.; Bertelli, A.; Tillement, J.P. Evidence for resveratrol-induced preservation of brain mitochondria functions after hypoxia-reoxygenation. Drugs Exp. Clin. Res. 2003, 29, 227-233
70. Gatson, J.W.; Liu, M.M.; Abdelfattah, K.; Wigginton, J.G.; Smith, S.; Wolf, S.; Minei, J.P. Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury. J. Trauma Acute Care Surg. 2013, 74, 470-474
71. Ates, O.; Cayli, S.; Altinoz, E.; Gurses, I.; Yucel, N.; Sener, M.; Kocak, A.; Yologlu, S. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol. Cell. Biochem. 2007, 294, 137-144
72. Zhang, F.; Wang, H.; Wu, Q.; Lu, Y.; Nie, J.; Xie, X.; Shi, J. Resveratrol protects cortical neurons against microglia-mediated neuroinflammation. Phytother. Res. 2013, 27, 344-349
73. Zhang, Y.; Tian, F.; Xiao, Q.; Hu, Y.; Li, J.; Jiang, F.; Liu, Y. Exploiting the role of resveratrol in rat mitochondrial permeability transition. J. Membr. Biol. 2013, 246, 365-373
74. Ma, X.; Tian, X.; Huang, X.; Yan, F.; Qiao, D. Resveratrol-induced mitochondrial dysfunction and apoptosis are associated with Ca2+ and mcicr-mediated mpt activation in hepg2 cells. Mol. Cell. Biochem. 2007, 302, 99-109
75. Chen, Q.Y.; Lu, G.H.; Wu, Y.Q.; Zheng, Y.; Xu, K.; Wu, L.J.; Jiang, Z.Y.; Feng, R.; Zhou, J.Y. Curcumin induces mitochondria pathway mediated cell apoptosis in a549 lung adenocarcinoma cells. Oncol. Rep. 2010, 23, 1285-1292
76. Gopal, P.K.; Paul, M.; Paul, S. Curcumin induces caspase mediated apoptosis in jurkat cells by disrupting the redox balance. Asian Pac. J. Cancer Prev. 2014, 15, 93-100
77. Thayyullathil, F.; Chathoth, S.; Hago, A.; Patel, M.; Galadari, S. Rapid reactive oxygen species (ros) generation induced by curcumin leads to caspase-dependent and-independent apoptosis in l929 cells. Free Rad. Biol. Med. 2008, 45, 1403-1412
78. Hirzel, E.; Lindinger, P.W.; Maseneni, S.; Giese, M.; Rhein, V.V.; Eckert, A.; Hoch, M.; Krahenbuhl, S.; Eberle, A.N. Differential modulation of ros signals and other mitochondrial parameters by the antioxidants mitoq, resveratrol and curcumin in human adipocytes. J. Recept. Signal Transduct. Res. 2013, 33, 304-312
79. Chan, W.H.; Wu, H.J.; Hsuuw, Y.D. Curcumin inhibits ros formation and apoptosis in methylglyoxal-treated human hepatoma g2 cells. Ann. New York Acad. Sci. 2005, 1042, 372-378
80. Sakurai, R.; Villarreal, P.; Husain, S.; Liu, J.; Sakurai, T.; Tou, E.; Torday, J.S.; Rehan, V.K. Curcumin protects the developing lung against long-term hyperoxic injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013, 305, L301-L311
81. Woo, J.M.; Shin, D.Y.; Lee, S.J.; Joe, Y.; Zheng, M.; Yim, J.H.; Callaway, Z.; Chung, H.T. Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen. Mol. Vis. 2012, 18, 901-908
82. Jiang, H.; Tian, X.; Guo, Y.; Duan, W.; Bu, H.; Li, C. Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity. Biol. Pharm. Bull. 2011, 34, 1194-1197
83. Cerny, D.; Lekic, N.; Vanova, K.; Muchova, L.; Horinek, A.; Kmonickova, E.; Zidek, Z.; Kamenikova, L.; Farghali, H. Hepatoprotective effect of curcumin in lipopolysaccharide/-galactosamine model of liver injury in rats: Relationship to ho-1/co antioxidant system. Fitoterapia 2011, 82, 786-791
84. Chang, Z.; Xing, J.; Yu, X. Curcumin induces osteosarcoma mg63 cells apoptosis via ros/cyto-c/caspase-3 pathway. Tumour Biol. 2014, 35, 753-758
85. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
86. Klickovic, U.; Doberer, D.; Gouya, G.; Aschauer, S.; Weisshaar, S.; Storka, A.; Bilban, M.; Wolzt, M. Human pharmacokinetics of high dose oral curcumin and its effect on heme oxygenase-1 expression in healthy male subjects. BioMed Res. Int. 2014, 2014, 458592
87. Walle, T.; Hsieh, F.; DeLegge, M.H.; Oatis, J.E., Jr.; Walle, U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabol. Disposit. 2004, 32, 1377-1382
88. Shelma, R.; Sharma, C.P. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability. Carbohydr. Polym. 2013, 95, 441-448
89. Wang, K.; Zhang, T.; Liu, L.; Wang, X.; Wu, P.; Chen, Z.; Ni, C.; Zhang, J.; Hu, F.; Huang, J. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int. J. Nanomed. 2012, 7, 4487-4497
90. Verderio, P.; Bonetti, P.; Colombo, M.; Pandolfi, L.; Prosperi, D. Intracellular drug release from curcumin-loaded plga nanoparticles induces g2/m block in breast cancer cells. Biomacromolecules 2013, 14, 672-682
91. Singh, G.; Pai, R.S. Optimized plga nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential. Expert Opin. Drug Deliv. 2014, 11, 647-659
92. Reddy, C.A.; Somepalli, V.; Golakoti, T.; Kanugula, A.K.; Karnewar, S.; Rajendiran, K.; Vasagiri, N.; Prabhakar, S.; Kuppusamy, P.; Kotamraju, S. et al. Mitochondrial-targeted curcuminoids: A strategy to enhance bioavailability and anticancer efficacy of curcumin. PloS One 2014, 9, e89351
93. Boddupalli, S.; Mein, J.R.; Lakkanna, S.; James, D.R. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: Perspectives in maintaining the antioxidant activity of vitamins a, c, and e. Front. Genet. 2012, 3, 7
94. Scarpulla, R.C. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim. Biophys. Acta 2002, 1576, 1-14
95. Scarpulla, R.C. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 2002, 286, 81-89
96. Scarpulla, R.C. Nuclear control of respiratory chain expression in mammalian cells. J. Bioenerg. Biomembr. 1997, 29, 109-119
97. Wu, Z.; Puigserver, P.; Andersson, U.; Zhang, C.; Adelmant, G.; Mootha, V.; Troy, A.; Cinti, S.; Lowell, B.; Scarpulla, R.C. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator pgc-1. Cell 1999, 98, 115-124
98. Boss, O.; Hagen, T.; Lowell, B.B. Uncoupling proteins 2 and 3: Potential regulators of mitochondrial energy metabolism. Diabetes 2000, 49, 143-156
99. Jastroch, M.; Wuertz, S.; Kloas, W.; Klingenspor, M. Uncoupling protein 1 in fish uncovers an ancient evolutionary history of mammalian nonshivering thermogenesis. Physiol. Genomics 2005, 22, 150-156
100. Nedergaard, J.; Golozoubova, V.; Matthias, A.; Asadi, A.; Jacobsson, A.; Cannon, B. Ucp1: The only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim. Biophys. Acta 2001, 1504, 82-106
101. Duncan, J.G.; Fong, J.L.; Medeiros, D.M.; Finck, B.N.; Kelly, D.P. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/pgc-1alpha gene regulatory pathway. Circulation 2007, 115, 909-917
102. Kelly, L.J.; Vicario, P.P.; Thompson, G.M.; Candelore, M.R.; Doebber, T.W.; Ventre, J.; Wu, M.S.; Meurer, R.; Forrest, M.J.; Conner, M.W. et al. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (ucp-1, ucp-2, ucp-3) gene expression. Endocrinol. 1998, 139, 4920-4927
103. Brun, S.; Carmona, M.C.; Mampel, T.; Vinas, O.; Giralt, M.; Iglesias, R.; Villarroya, F. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: A potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 1999, 48, 1217-1222
104. Monsalve, M.; Wu, Z.; Adelmant, G.; Puigserver, P.; Fan, M.; Spiegelman, B.M. Direct coupling of transcription and mrna processing through the thermogenic coactivator pgc-1. Mol. Cell. 2000, 6, 307-316
105. Guha, M.; Avadhani, N.G. Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion 2013, 13, 577-591
106. Chen, X.J.; Wang, X.; Kaufman, B.A.; Butow, R.A. Aconitase couples metabolic regulation to mitochondrial DNA maintenance. Science 2005, 307, 714-717
107. Jones, A.W.; Yao, Z.; Vicencio, J.M.; Karkucinska-Wieckowska, A.; Szabadkai, G. Pgc-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling. Mitochondrion 2012, 12, 86-99
108. Dugas, B.; Charbonnier, S.; Baarine, M.; Ragot, K.; Delmas, D.; Menetrier, F.; Lherminier, J.; Malvitte, L.; Khalfaoui, T.; Bron, A. et al. Effects of oxysterols on cell viability, inflammatory cytokines, vegf, and reactive oxygen species production on human retinal cells: Cytoprotective effects and prevention of vegf secretion by resveratrol. Eur. J. Nutr. 2010, 49, 435-446
109. Csaki, C.; Keshishzadeh, N.; Fischer, K.; Shakibaei, M. Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem. Pharmacol. 2008, 75, 677-687
110. Rahman, I.; Biswas, S.K.; Kirkham, P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 2006, 72, 1439-1452
111. Jeong, S.H.; Song, I.S.; Kim, H.K.; Lee, S.R.; Song, S.; Suh, H.; Yoon, Y.G.; Yoo, Y.H.; Kim, N.; Rhee, B.D.; et al. An analogue of resveratrol hs-1793 exhibits anticancer activity against mcf-7 cells via inhibition of mitochondrial biogenesis gene expression. Mol. Cells 2012, 34, 357-365
112. Darvekar, S.R.; Elvenes, J.; Brenne, H.B.; Johansen, T.; Sjottem, E. Spbp is a sulforaphane induced transcriptional coactivator of nrf2 regulating expression of the autophagy receptor p62/sqstm1. PloS One 2014, 9, e85262
113. Puissant, A.; Fenouille, N.; Auberger, P. When autophagy meets cancer through p62/sqstm1. Am. J. Cancer Res. 2012, 2, 397-413
114. Das, S.; Mitrovsky, G.; Vasanthi, H.R.; Das, D.K. Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of sirt1-sirt3-foxo3-pink1-parkin. Oxid. Med. Cell. Longev. 2014, 2014, 345105
115. Kirstein-Miles, J.; Morimoto, R.I. Peptides signal mitochondrial stress. Cell Metabol. 2010, 11, 177-178
116. Houtkooper, R.H.; Mouchiroud, L.; Ryu, D.; Moullan, N.; Katsyuba, E.; Knott, G.; Williams, R.W.; Auwerx, J. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 2013, 497, 451-457
117. Harrison, D.E.; Strong, R.; Sharp, Z.D.; Nelson, J.F.; Astle, C.M.; Flurkey, K.; Nadon, N.L.; Wilkinson, J.E.; Frenkel, K.; Carter, C.S. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460, 392-395
118. Robida-Stubbs, S.; Glover-Cutter, K.; Lamming, D.W.; Mizunuma, M.; Narasimhan, S.D.; Neumann-Haefelin, E.; Sabatini, D.M.; Blackwell, T.K. Tor signaling and rapamycin influence longevity by regulating skn-1/nrf and daf-16/foxo. Cell Metabol. 2012, 15, 713-724
119. Kirchman, P.A.; Kim, S.; Lai, C.Y.; Jazwinski, S.M. Interorganelle signaling is a determinant of longevity in saccharomyces cerevisiae. Genetics 1999, 152, 179-190
120. Copeland, J.M.; Cho, J.; Lo, T., Jr.; Hur, J.H.; Bahadorani, S.; Arabyan, T.; Rabie, J.; Soh, J.; Walker, D.W. Extension of drosophila life span by rnai of the mitochondrial respiratory chain. Curr. Biol. 2009, 19, 1591-1598
121. Feng, J.; Bussiere, F.; Hekimi, S. Mitochondrial electron transport is a key determinant of life span in caenorhabditis elegans. Dev. Cell 2001, 1, 633-644
122. Lapointe, J.; Stepanyan, Z.; Bigras, E.; Hekimi, S. Reversal of the mitochondrial phenotype and slow development of oxidative biomarkers of aging in long-lived mclk1+/- mice. J. Biol. Chem. 2009, 284, 20364-20374
123. Van Raamsdonk, J.M.; Hekimi, S. Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in caenorhabditis elegans. PLoS Genetics 2009, 5, e1000361
124. Yang, W.; Li, J.; Hekimi, S. A measurable increase in oxidative damage due to reduction in superoxide detoxification fails to shorten the life span of long-lived mitochondrial mutants of caenorhabditis elegans. Genetics 2007, 177, 2063-2074
125. Durieux, J.; Wolff, S.; Dillin, A. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 2011, 144, 79-91
126. Tamir, S.; Zuris, J.A.; Agranat, L.; Lipper, C.H.; Conlan, A.R.; Michaeli, D.; Harir, Y.; Paddock, M.L.; Mittler, R.; Cabantchik, Z.I. et al. Nutrient-deprivation autophagy factor-1 (naf-1): Biochemical properties of a novel cellular target for anti-diabetic drugs. PloS One 2013, 8, e61202
127. Yu, Z.; Pestell, T.G.; Lisanti, M.P.; Pestell, R.G. Cancer stem cells. Int. J. Biochem. Cell Biol. 2012, 44, 2144-2151
128. Bruce, W.R.; Van Der Gaag, H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 1963, 199, 79-80
129. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M.A.; Dick, J.E. A cell initiating human acute myeloid leukaemia after transplantation into scid mice. Nature 1994, 367, 645-648
130. Bonnet, D.; Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 1997, 3, 730-737
131. Li, C.; Heidt, D.G.; Dalerba, P.; Burant, C.F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M.F.; Simeone, D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67, 1030-1037
132. Hermann, P.C.; Huber, S.L.; Herrler, T.; Aicher, A.; Ellwart, J.W.; Guba, M.; Bruns, C.J.; Heeschen, C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1, 313-323
133. Singh, S.K.; Hawkins, C.; Clarke, I.D.; Squire, J.A.; Bayani, J.; Hide, T.; Henkelman, R.M.; Cusimano, M.D.; Dirks, P.B. Identification of human brain tumour initiating cells. Nature 2004, 432, 396-401
134. Eramo, A.; Lotti, F.; Sette, G.; Pilozzi, E.; Biffoni, M.; Di Virgilio, A.; Conticello, C.; Ruco, L.; Peschle, C.; De Maria, R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15, 504-514
135. Chan, K.S.; Espinosa, I.; Chao, M.; Wong, D.; Ailles, L.; Diehn, M.; Gill, H.; Presti, J., Jr.; Chang, H.Y.; van de Rijn, M.; et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Nat. Acad. Sci. USA 2009, 106, 14016-14021
136. Gu, G.; Yuan, J.; Wills, M.; Kasper, S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 2007, 67, 4807-4815
137. Zimmerer, R.M.; Korn, P.; Demougin, P.; Kampmann, A.; Kokemuller, H.; Eckardt, A.M.; Gellrich, N.C.; Tavassol, F. Functional features of cancer stem cells in melanoma cell lines. Cancer Cell Int. 2013, 13, 78
138. Zhang, S.; Balch, C.; Chan, M.W.; Lai, H.C.; Matei, D.; Schilder, J.M.; Yan, P.S.; Huang, T.H.; Nephew, K.P. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008, 68, 4311-4320
139. Okamoto, A.; Chikamatsu, K.; Sakakura, K.; Hatsushika, K.; Takahashi, G.; Masuyama, K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009, 45, 633-639
140. Ricci-Vitiani, L.; Lombardi, D.G.; Pilozzi, E.; Biffoni, M.; Todaro, M.; Peschle, C.; De Maria, R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445, 111-115
141. Dalerba, P.; Dylla, S.J.; Park, I.K.; Liu, R.; Wang, X.; Cho, R.W.; Hoey, T.; Gurney, A.; Huang, E.H.; Simeone, D.M. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Nat. Acad. Sci. USA 2007, 104, 10158-10163
142. Sainz, B., Jr.; Heeschen, C. Standing out from the crowd: Cancer stem cells in hepatocellular carcinoma. Cancer cell 2013, 23, 431-433
143. Yamashita, T.; Wang, X.W. Cancer stem cells in the development of liver cancer. J. Clin. Invest. 2013, 123, 1911-1918
144. Ponti, D.; Costa, A.; Zaffaroni, N.; Pratesi, G.; Petrangolini, G.; Coradini, D.; Pilotti, S.; Pierotti, M.A.; Daidone, M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005, 65, 5506-5511
145. Soltysova, A.; Altanerova, V.; Altaner, C. Cancer stem cells. Neoplasma 2005, 52, 435-440
146. Nakagawara, A.; Ohira, M. Comprehensive genomics linking between neural development and cancer: Neuroblastoma as a model. Cancer Lett. 2004, 204, 213-224
147. Cozzio, A.; Passegue, E.; Ayton, P.M.; Karsunky, H.; Cleary, M.L.; Weissman, I.L. Similar mll-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003, 17, 3029-3035
148. Clarke, M.F.; Dick, J.E.; Dirks, P.B.; Eaves, C.J.; Jamieson, C.H.; Jones, D.L.; Visvader, J.; Weissman, I.L.; Wahl, G.M. Cancer stem cells—perspectives on current status and future directions: Aacr workshop on cancer stem cells. Cancer Res. 2006, 66, 9339-9344
149. Zhou, J.; Zhang, Y. Cancer stem cells: Models, mechanisms and implications for improved treatment. Cell Cycle 2008, 7, 1360-1370
150. Liao, J.; Qian, F.; Tchabo, N.; Mhawech-Fauceglia, P.; Beck, A.; Qian, Z.; Wang, X.; Huss, W.J.; Lele, S.B.; Morrison, C.D.; et al. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PloS One 2014, 9, e84941
151. Luk, S.U.; Yap, W.N.; Chiu, Y.T.; Lee, D.T.; Ma, S.; Lee, T.K.; Vasireddy, R.S.; Wong, Y.C.; Ching, Y.P.; Nelson, C. et al. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int. J. Cancer. J. Cancer 2011, 128, 2182-2191
152. Todaro, M.; Alea, M.P.; Di Stefano, A.B.; Cammareri, P.; Vermeulen, L.; Iovino, F.; Tripodo, C.; Russo, A.; Gulotta, G.; Medema, J.P. et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1, 389-402
153. Phillips, T.M.; McBride, W.H.; Pajonk, F. The response of cd24(-/low)/cd44+ breast cancer-initiating cells to radiation. J. Nat. Cancer Inst. 2006, 98, 1777-1785
154. Wanet, A.; Tacheny, A.; Arnould, T.; Renard, P. Mir-212/132 expression and functions: Within and beyond the neuronal compartment. Nucleic Acids Res. 2012, 40, 4742-4753
155. Ye, X.Q.; Li, Q.; Wang, G.H.; Sun, F.F.; Huang, G.J.; Bian, X.W.; Yu, S.C.; Qian, G.S. Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int. J. Cancer. J. Int. Cancer 2011, 129, 820-831
156. Tang, S.N.; Singh, C.; Nall, D.; Meeker, D.; Shankar, S.; Srivastava, R.K. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (egcg) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J. Mol. Signaling 2010, 5, 14
157. Shankar, S.; Nall, D.; Tang, S.N.; Meeker, D.; Passarini, J.; Sharma, J.; Srivastava, R.K. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and krasg12d transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PloS One 2011, 6, e16530
158. Srivastava, R.K.; Tang, S.N.; Zhu, W.; Meeker, D.; Shankar, S. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. Front. Biosci. 2011, 3, 515-528
159. Alvero, A.B.; Montagna, M.K.; Holmberg, J.C.; Craveiro, V.; Brown, D.; Mor, G. Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol. Cancer Ther. 2011, 10, 1385-1393
160. Fong, D.; Yeh, A.; Naftalovich, R.; Choi, T.H.; Chan, M.M. Curcumin inhibits the side population (sp) phenotype of the rat c6 glioma cell line: Towards targeting of cancer stem cells with phytochemicals. Cancer Lett. 2010, 293, 65-72
161. Bleau, A.M.; Hambardzumyan, D.; Ozawa, T.; Fomchenko, E.I.; Huse, J.T.; Brennan, C.W.; Holland, E.C. Pten/pi3k/akt pathway regulates the side population phenotype and abcg2 activity in glioma tumor stem-like cells. Cell Stem Cell 2009, 4, 226-235
162. Fulda, S. Resveratrol and derivatives for the prevention and treatment of cancer. Drug Discov. Today 2010, 15, 757-765
163. Pan, Z.; Agarwal, A.K.; Xu, T.; Feng, Q.; Baerson, S.R.; Duke, S.O.; Rimando, A.M. Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol. BMC Med. Genom. 2008, 1, 7.